BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4023922)

  • 1. Protein synthesis in the tumor-influenced hepatocyte.
    Warren RS; Jeevanandam M; Brennan MF
    Surgery; 1985 Aug; 98(2):275-82. PubMed ID: 4023922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyte.
    Blumberg D; Burt ME; Kher U; Brennan MF
    J Surg Res; 1993 Nov; 55(5):565-9. PubMed ID: 8231177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in oxidative metabolism and glutamine transport support glucose production in the tumor-influenced hepatocyte.
    Fischer CP; Bode BP; Hurley BP; Souba WW
    J Surg Res; 1997 May; 69(2):379-84. PubMed ID: 9224411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin protects against hepatic bioenergetic deterioration induced by cancer cachexia: an in vivo 31P magnetic resonance spectroscopy study.
    Brauer M; Inculet RI; Bhatnagar G; Marsh GD; Driedger AA; Thompson RT
    Cancer Res; 1994 Dec; 54(24):6383-6. PubMed ID: 7987832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein synthesis in liver tissue under the influence of a methylcholanthrene-induced sarcoma in mice.
    Lundholm K; Ekman L; Edström S; Karlberg I; Jagenburg R; Scherstén T
    Cancer Res; 1979 Nov; 39(11):4657-61. PubMed ID: 498094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased whole-body protein and glutamine turnover in advanced cancer is not matched by an increased muscle protein and glutamine turnover.
    de Blaauw I; Heeneman S; Deutz NE; von Meyenfeldt MF
    J Surg Res; 1997 Feb; 68(1):44-55. PubMed ID: 9126194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy depletion in the liver and in isolated hepatocytes of tumor-bearing animals.
    Tsuburaya A; Blumberg D; Burt M; Brennan MF
    J Surg Res; 1995 Oct; 59(4):421-7. PubMed ID: 7564311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional and translational activity in relation to oxygen consumption in isolated liver cells from sarcoma-bearing mice.
    Ternell M; Edström S; Lundholm K
    Cancer Biochem Biophys; 1983; 6(4):213-9. PubMed ID: 6193866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in whole body, muscle, liver, and tumor tissue protein synthesis and degradation in Novikoff hepatoma and Yoshida sarcoma tumor growth studied in vivo.
    Tayek JA; Blackburn GL; Bistrian BR
    Cancer Res; 1988 Mar; 48(6):1554-8. PubMed ID: 3345528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered amino acid kinetics in rats with progressive tumor growth.
    Kawamura I; Moldawer LL; Keenan RA; Batist G; Bothe A; Bistrian BR; Blackburn GL
    Cancer Res; 1982 Mar; 42(3):824-9. PubMed ID: 7059980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for elevated breakdown rate of skeletal muscles in weight-losing, tumor-bearing mice.
    Svaninger G; Bennegard K; Ekman L; Ternell M; Lundholm K
    J Natl Cancer Inst; 1983 Aug; 71(2):341-6. PubMed ID: 6576191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IRS-1 phosphorylation and the alterations of GLUT4 in isolated adipocytes from cachectic tumor-bearing rats.
    Yoshikawa T; Noguchi Y; Satoh S
    Biochem Biophys Res Commun; 1999 Mar; 256(3):676-81. PubMed ID: 10080958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticatabolic effect of the beta 2-agonist cimaterol in vivo in tumor-bearing animals.
    Stallion A; Foley-Nelson T; Chance WT; James JH; Fischer JE
    J Surg Res; 1995 Sep; 59(3):387-92. PubMed ID: 7643598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced alterations in hepatic malic enzyme and carnitine palmitoyltransferase activity.
    Noguchi Y; Vydelingum NA; Brennan MF
    J Surg Res; 1993 Oct; 55(4):357-63. PubMed ID: 8412123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reutilization of amino acid carbons in relation to albumin turnover in nongrowing mice with sarcoma.
    Karlberg I; Ekman L; Edström S; Scherstén T; Lundholm K
    Cancer Res; 1982 Jun; 42(6):2284-8. PubMed ID: 7074611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
    Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of expression of the intestinal glutamine transporter ATB0 in tumor-bearing rats.
    Choudry HA; Souba WW; Lin C; Meng Q; Karinch AM; Huang J; Pan M
    Ann Surg Oncol; 2006 Dec; 13(12):1747-53. PubMed ID: 17006743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumor.
    Pain VM; Randall DP; Garlick PJ
    Cancer Res; 1984 Mar; 44(3):1054-7. PubMed ID: 6692391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endotoxin challenge on hepatic amino acid transport during cancer.
    Easson AM; Bode BP; Fischer CP; Souba WW
    J Surg Res; 1998 Jun; 77(1):29-34. PubMed ID: 9698528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hepatic protein synthesis in vivo versus in vitro in the tumor-bearing rat.
    Warren RS; Jeevanandam M; Brennan MF
    J Surg Res; 1987 Jan; 42(1):43-50. PubMed ID: 3543498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.